Evrofarma SA Total Assets
Evrofarma SA total assets. Based on the latest financial reports, Evrofarma SA (EVROF) holds total assets worth €48.81 Million EUR (≈ $57.07 Million USD) as of December 2022. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Evrofarma SA (EVROF) cash flow conversion for how efficiently the company converts equity into cash flow.
Total Assets of Evrofarma SA (2014–2022)
Total assets of Evrofarma SA from 2014 to 2022. This chart illustrates how Evrofarma SA's total assets have evolved over time, based on quarterly financial data. See Evrofarma SA (EVROF) share price today for real-time trading data and today's change.
Evrofarma SA - Asset Composition Analysis
Evrofarma SA Total Assets Breakdown (December 2022)
Evrofarma SA total assets breakdown as of December 2022. Evrofarma SA's total assets of €48.81 Million consist of 38.3% current assets and 61.7% non-current assets. Explore EVROF working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €1.44 Million | 0.0% |
| Accounts Receivable | €11.72 Million | 24.0% |
| Inventory | €5.56 Million | 11.4% |
| Property, Plant & Equipment | €24.15 Million | 49.5% |
| Intangible Assets | €59.00K | 0.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2022)
This chart illustrates how Evrofarma SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Evrofarma SA's current assets represent 38.3% of total assets in 2022, an increase from 29.8% in 2014.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, down from 0.2% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is property, plant & equipment at 49.5% of total assets.
Evrofarma SA Competitors by Total Assets
Key competitors of Evrofarma SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF128.38 Billion |
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
Glanbia PLC
IR:GL9
|
Ireland | €3.99 Billion |
|
Unibel S.A
PA:UNBL
|
France | €4.09 Billion |
|
Xiamen Kingdomway Group Co
SHE:002626
|
China | CN¥8.38 Billion |
|
Qianhe Condiment&Food Co Ltd
SHG:603027
|
China | CN¥4.46 Billion |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
Mexico | MX$48.32 Billion |
|
Avanti Feeds Limited
NSE:AVANTIFEED
|
India | Rs42.35 Billion |
Evrofarma SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.38 | 1.41 | 1.01 |
| Quick Ratio | 0.84 | 1.03 | 0.80 |
| Cash Ratio | 0.00 | 0.09 | 0.00 |
| Working Capital | €6.57 Million | €6.57 Million | €111.00K |
Evrofarma SA - Advanced Valuation Insights
This section examines the relationship between Evrofarma SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 1.07 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | €48.81 Million |
| Market Capitalization | $52.35 Million USD |
Valuation Analysis
Above Book Valuation: The market values Evrofarma SA's assets above their book value (1.07x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Evrofarma SA's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Evrofarma SA (2014–2022)
The table below shows the annual total assets of Evrofarma SA from 2014 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | €48.81 Million ≈ $57.07 Million |
+4.93% |
| 2021-12-31 | €46.52 Million ≈ $54.39 Million |
+0.31% |
| 2020-12-31 | €46.38 Million ≈ $54.22 Million |
+12.56% |
| 2019-12-31 | €41.20 Million ≈ $48.17 Million |
-6.85% |
| 2018-12-31 | €44.23 Million ≈ $51.71 Million |
-1.92% |
| 2017-12-31 | €45.09 Million ≈ $52.72 Million |
+3.07% |
| 2016-12-31 | €43.75 Million ≈ $51.15 Million |
-1.34% |
| 2015-12-31 | €44.35 Million ≈ $51.85 Million |
-6.18% |
| 2014-12-31 | €47.27 Million ≈ $55.26 Million |
-- |
About Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.